Progress in cardiovascular diseases over the years reflects advancements in medical science, technology, and healthcare delivery, leading to improved prevention, diagnosis, and treatment of various cardiovascular conditions. Innovations in imaging modalities, such as cardiac MRI and CT angiography, allow for more accurate and detailed visualization of the heart and blood vessels. Breakthroughs in interventional cardiology, including the development of drug-eluting stents and minimally invasive procedures like transcatheter valve replacements, have revolutionized the treatment of coronary artery disease and structural heart disorders. Progress in pharmacotherapy has introduced novel medications targeting specific pathways to manage hypertension, dyslipidemia, and heart failure more effectively. Moreover, the integration of data-driven approaches, artificial intelligence, and personalized medicine holds promise for further advancements in tailoring cardiovascular care to individual patient needs. These collective efforts contribute to reducing mortality, improving quality of life, and shaping a more optimistic outlook for individuals facing cardiovascular diseases.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt